National Health Investors vs Omega Healthcare Investors
NHI and OHI side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How NHI and OHI compare
Omega Healthcare Investors is the larger company, worth 4.8 times as much as National Health Investors ($14.2B against $2.9B).
On earnings, Omega Healthcare Investors is cheaper: it trades at 16.9× trailing earnings, against 17.3× for National Health Investors.
National Health Investors grew revenue faster over the last twelve months (23.9% versus 15.0% for Omega Healthcare Investors).
Omega Healthcare Investors keeps more of each dollar of sales as profit, with a net margin of 67.0% compared with 38.6% at National Health Investors.
Both pay dividends: National Health Investors yields 6.2% and Omega Healthcare Investors 4.3%.
National Health Investors scores higher on the StockData Score (14 against 11 for Omega Healthcare Investors), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | NHI | OHI |
|---|---|---|
| Size and price | ||
| Market cap | $2.9B | $14.2B |
| Share price | $59.98 | $46.78 |
| Change, 1 year | −22.3% | 6.4% |
| Change, 5 years | 13.7% | 66.8% |
| Beta (5Y) | −0.49 | −0.13 |
| Employees | 32 | 69 |
| StockData Score | ||
| Total score | 14 (better) | 11 |
| Valuation score | 3 | 3 |
| Growth score | 5 (better) | 3 |
| Performance score | 3 (better) | 2 |
| Health score | 0 | 0 |
| Dividend score | 3 | 3 |
| Valuation | ||
| P/E | 17.3× | 16.9× (better) |
| P/S | 6.8× (better) | 11.1× |
| P/B | 1.9× (better) | 2.6× |
| EV/EBITDA | – | 10.0× |
| PEG | 0.65 (better) | 6.68 |
| Fair value | $70.31 | $51.90 |
| Margin of safety | 14.7% (better) | 9.9% |
| Growth | ||
| Revenue growth (TTM) | 23.9% (better) | 15.0% |
| Revenue growth, 5Y average | 2.5% | 5.9% (better) |
| Net income growth (TTM) | 16.7% | 82.4% (better) |
| EPS growth (TTM) | 10.5% | 73.1% (better) |
| EPS growth, 5Y average | −6.1% | 22.6% (better) |
| Profitability | ||
| Net margin | 38.6% | 67.0% (better) |
| Return on equity | 10.9% | 16.5% (better) |
| Financial health | ||
| Altman Z-score | 2.77 | 2.80 (better) |
| Piotroski F-score | 5 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | 6.2% (better) | 4.3% |
| Payout ratio | 105% | 92.6% |
| Years of dividend growth | 1 (better) | 0 |
| Dividend growth, 5Y average | −4.6% | 0.00% (better) |
| Buyback yield | −3.5% | – |
| Shareholder yield | 2.7% | 4.3% (better) |
| Ownership | ||
| Held by institutions | 77.7% | 81.8% |
| Held by insiders | 2.5% | 0.19% |
| Insider net buying, 12 months | $167K (better) | $0 |
| Short interest, % of float | 4.6% | 4.9% |
Go deeper
- NHI stock overview
- NHI income statement
- NHI valuation and score
- OHI stock overview
- OHI income statement
- OHI valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.